Prof. Dr. Markus Neurath

Lehrstuhl für Innere Medizin I (Medizin 1)

Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS (2018) Schellhaas B, Hammon M, Strobel D, Pfeifer L, Kielisch C, Görtz R, Janka RM, et al. Journal article IL-3 drives IL-10-secreting Tr1 cells to counteract experimental colitis (2018) Zundler S, Spocinska M, Popp V, Becker E, Atreya R, Neufert C, Atreya I, et al. Conference contribution Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis (2018) Atreya R, Reinisch W, Peyrin-Biroulet L, Scaldaferri F, Admyre C, Knittel T, Kowalski J, et al. Journal article Chronic intestinal inflammation in mice expressing viral Flip in epithelial cells (2018) Ruder B, Murtadak V, Stürzl M, Wirtz S, Distler U, Tenzer S, Mahapatro M, et al. Journal article Confocal Laser Endomicroscopy for Diagnosing Malignant Pleural Effusions (2018) Zirlik S, Hildner K, Rieker R, Neurath M, Fuchs F, Vieth M Journal article Differences in the bacterial pattern of histamine intolerant patients (2018) Schink M, Tietz E, Dieterich W, Pinzer TC, Wirtz S, Neurath M, Zopf Y Conference contribution Acoustic radiation force impulse (ARFI) elastography of the bowel wall as a possible marker of inflammatory activity in patients with Crohn's disease (2018) Görtz R, Lueke C, Wildner D, Vitali F, Neurath M, Strobel D Journal article Contrast-Enhanced µCT for Visualizing and Evaluating Murine Intestinal Inflammation (2018) Jung D, Heiß R, Kramer V, Thoma OM, Regensburger A, Rascher W, Uder M, et al. Journal article Detection by flow cytometry of anti-neutrophil cytoplasmic antibodies in a novel approach based on neutrophil extracellular traps (2018) Roitsch S, Goesswein S, Neurath M, Leppkes M Journal article Clinical outcomes and immunogenicity analysis over 6 months following a switch from originator infliximab (Remicade (R)) to the biosimilar SB2 (Flixabi (R)) in inflammatory bowel disease patients (2018) Fischer SM, Klenske E, Schmitt H, Vitali F, Hirschmann S, Koch F, Ramming A, et al. Conference contribution